Русский

Pharmaceutical Industry Information Portal

HomeTagsOlokizumab

All posts by tag

olokizumab

Manufacturers News

R-Pharm presented results of phase III global research program for rheumatoid arthritis drug, novel IL-6 inhibitor Olokizumab

Techno -
In the framework of the annual ACR Convergence 2021, R-Pharm Group presented successful results of olokizumab in two randomized clinical trials of phase III...
Discovery and Development

R-Pharm presented results of phase III global research program – CREDO

Techno -
In the framework of the annual ACR Convergence 2021, R-Pharm Group presented successful results of olokizumab in two randomized clinical trials of phase III global research program — CREDO (Clinical RhEumatoid Arthritis Development...
Manufacturers News

Russian Health Ministry recommends RA drug olokizumab for patients with COVID-19 of any severity

Techno -
The Ministry of Health of the Russian Federation has issued the 12th version of the Temporary guidelines for the prevention, diagnosis and treatment of...
spot_img

Expert Articles

spot_img

Information Internet project PharmProm.Net dedicated to the pharmaceutical industry in the world. It contains a contact base of organizations, enterprises, companies associated with the pharmaceutical market. The editorial staff of the PharmProm.Net portal offers cooperation in the field of information promotion and advertising in the pharmaceutical market.

Read our Russian-language online magazine

Categories